Poster
23

VHH drug discovery using synthetic libraries

Authors

D Knight1
1 Isogenica Ltd, UK

Abstract

Isogenica uses diverse fully synthetic camelid domain antibody (VHH) libraries for internal and partnered drug discovery. Humanised synthetic libraries offer several advantages over immunisation or the use of naïve libraries, including diversity and the speed of clone isolation. During the drug discovery process, many clones might meet the desired functional properties but contain liabilities that need to be addressed before the start of the development process. Synthetic libraries include design features that reduce the number and type of liabilities thereby reducing the time of drug development. Here we show an improved library and functional data on two projects with clones generated from the llamdA library.

Hosted By

ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Login
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021